Key takeaways
HCPCS code J0395 describes injection, arbutamine HCl, 1 mg, a deleted Level II J-code for a pharmacological cardiac stress agent.
J0395 is no longer valid on current claims, so verify code status before you bill any historical encounter.
No official replacement exists, so use J3490 for outstanding claims and attach the drug name, dose, NDC, and a medical necessity narrative.
Arbutamine was overtaken in practice by adenosine, regadenoson, and dobutamine, all of which still have active J-codes.
Practice management software like Pabau helps billing teams track code status changes and keep claim documentation audit-ready.
HCPCS code J0395 is a Level II HCPCS J-code representing a single 1 mg unit of arbutamine hydrochloride given by injection. J-codes cover drugs administered by routes other than oral. J0395 sat in the J-series for injectable drugs billed to Medicare Part B and most commercial payers.
Code status: Is HCPCS code J0395 still active?
HCPCS code J0395 is deleted and no longer valid for billing. The Centers for Medicare and Medicaid Services (CMS) maintains the HCPCS code set. Deleted codes drop off the active list during annual or quarterly update cycles. Submitting a deleted code on a current claim triggers an automatic denial from Medicare and most commercial payers.
Practices with outstanding encounters billed under J0395 should check their timely filing limits before recoding. Encounters past the filing window cannot be corrected. Your medical record retention policy also decides whether the source documentation is still on hand to support a resubmission.
Drug information: Arbutamine HCl (GenESA)
Arbutamine hydrochloride, sold under the brand name GenESA, is a synthetic catecholamine developed as a pharmacological stress agent. It was given intravenously to reproduce the cardiovascular effects of exercise. That mattered for patients who could not manage a standard treadmill or bicycle stress protocol.
- Drug class: Synthetic catecholamine
- Brand name: GenESA, developed by Gensia Automedics and later marketed in the US by Sicor (Gensia Sicor)
- Mechanism of action: Raises heart rate, myocardial contractility, and cardiac output to mimic exercise stress for the diagnostic evaluation of coronary artery disease
- Route of administration: Intravenous infusion, closed-loop computer-controlled delivery
- Indication: Pharmacological cardiac stress testing in patients unable to exercise adequately
- Regulatory note: GenESA held FDA approval for cardiac stress testing, but market availability should be confirmed against current drug references
Clinical use: Pharmacological cardiac stress testing
Cardiac stress testing shows whether the heart gets enough blood flow during exertion. When a patient cannot exercise because of orthopedic, pulmonary, or deconditioning limits, a drug reproduces that demand instead. Arbutamine filled this role before adenosine, regadenoson, and dobutamine became the standard of care.
The workflow paired an arbutamine infusion with echocardiography or nuclear imaging. Clinicians looked for wall motion abnormalities or perfusion defects that point to coronary artery disease. Stress testing also runs well outside cardiology, in pre-operative workups and in the screening programs that longevity clinics offer. Billers needed the drug J-code and the companion imaging CPT code on the same claim.
Billing guidelines for HCPCS code J0395
When J0395 was active, billing followed the standard HCPCS Level II rules for injectable drugs. Because the code is now deleted, these guidelines apply only to historical claims inside your payer’s timely filing window. Practices that bill infused drugs every day, such as IV therapy providers, run the same checks on every drug line. Consult your MAC’s billing articles and your HIPAA-compliant billing policy before resubmitting anything.
Meeting medical documentation requirements means every encounter carries the physician order, the dose administered, the lot number where required, and any wastage note. Capture all of it at the point of care with digital intake forms rather than rebuilding it from memory weeks later.

Pro Tip
Audit any open accounts receivable for J0395 now. Flag encounters for recode to J3490 if they fall inside your payer’s timely filing window. For Medicare that window is usually 12 months from the date of service. Write off anything outside it and log the reason in your denial notes.
Medicare coverage and reimbursement
While J0395 was active, Medicare Part B covered arbutamine injection where medical necessity was established for pharmacological cardiac stress testing. CMS publishes billing and coding guidance for cardiovascular stress testing in its Medicare Physician Fee Schedule lookup tool.
Because J0395 is deleted, no active Medicare reimbursement rate applies. Fee schedule figures from prior years are historical only, so do not use them to set current billing expectations. Teams reviewing practice management and billing workflows for injectable drugs should confirm code status against the HCPCS annual update files CMS publishes each October.
ICD-10-CM diagnosis codes paired with J0395
When J0395 was active, pharmacological stress testing needed supporting ICD-10-CM documentation to establish medical necessity. The codes below reflect the conditions that historically supported coverage under Medicare LCD and NCD policies for cardiovascular stress testing. Payer acceptance varied, so always verify against the applicable LCD in your MAC jurisdiction.
Match the primary diagnosis to the documented clinical indication. Then add the secondary codes that explain why pharmacological stress was chosen over exercise testing. A musculoskeletal, neurological, or pulmonary code makes that case far better than a narrative note on its own.
Crosswalk: What code replaces J0395?
No official CMS crosswalk names a direct replacement for J0395. Arbutamine no longer appears in the active HCPCS J-code set, so practices with outstanding historical claims fall back to J3490, the unclassified drug code. That fallback only works with specific supporting documentation. Weak EHR integration is a common reason J3490 claims are denied, because the system never attaches the narrative and NDC automatically.
On a J3490 line, include the drug name “arbutamine hydrochloride,” the dose in milligrams, the NDC, and a short clinical narrative. The narrative explains why pharmacological stress was chosen over exercise testing. Many payers want this in Box 19 of the CMS-1500 or as an electronic attachment, so verify payer-specific rules before resubmitting.
Cardiovascular stress testing: Related HCPCS and CPT codes
Cardiac stress testing rarely involves a single code. The drug administration code, formerly J0395, paired with imaging or monitoring codes to capture the whole procedure. The codes below are active and relevant for practices billing pharmacological stress studies with other agents. Note how the unit size shifts between them: J1250 bills per 250 mg, while J0395 billed per 1 mg.
Coding tips and common billing errors
Denials on a deleted J-code trace back to a short list of avoidable mistakes. Each one below has a fix you can apply before the claim leaves your system. A routine medical chart audit catches most of them while the filing window is still open.
- Submitting J0395 on current claims: The most common error. Always verify code status before submission. A deleted code draws an immediate denial that cannot be appealed on the merits of the code itself.
- Missing JW or JZ modifier on historical claims: The JW modifier has applied to discarded drug from a single-dose vial since 2017. Mandatory JZ reporting, used when nothing is discarded, took effect July 1, 2023. Claims missing the required modifier are subject to rejection.
- Omitting the NDC from the claim line: Many Medicare Administrative Contractors and commercial payers require the 11-digit NDC for J-code claims. A missing NDC draws a denial even when the code was valid on the date of service.
- Incorrect unit reporting: J0395 billed at 1 mg per unit. If 5 mg was administered, the claim should report 5 units. Reporting the full dose as one unit underbills and can trigger review against the dose ranges on any prior approval.
- Using J3490 without supporting documentation: Unclassified drug codes need a drug-specific narrative. A bare J3490 claim line is almost always denied. Attach the drug name, strength, NDC, route, and medical necessity explanation.
- Exceeding timely filing limits before recoding: Once a claim sits outside the filing window, it cannot be corrected and resubmitted. Audit open receivables for J0395 now and work the ones nearest the deadline first.
Pro Tip
Track every J3490 claim you submit as a crosswalk for J0395. Create a denial bucket in your billing system for unclassified drug denials. Grouping them shows which payers accept the narrative and where the template needs work.
How Pabau keeps deleted-code claims audit-ready
A deleted code usually surfaces the same way. A denial lands, someone looks the code up, and the date of service is already months old. By then the clinical note, the NDC, and the wastage record may sit in three different places.
Practice management software like Pabau keeps those pieces on one patient record. Charting, consent forms, and the claim all attach to the same encounter. The evidence a J3490 line needs is there when the claim is built. Pabau’s claims management software then surfaces code and documentation problems before submission rather than after a denial.
The payoff is fewer claims returned for a missing narrative or NDC, and a clean trail when a payer audits. Esteem Life Medical Group moved to Pabau for that reason, needing record keeping that would stand up to strict regulatory review.
Keep drug claims accurate and audit-ready
Pabau links charting, consent forms, and claims on one patient record, so every drug line carries its order, dose, and documentation. Your team catches code and modifier problems before the claim goes out.
Conclusion
J0395 is a closed chapter, so what is left is cleanup. Pull your open receivables, sort the J0395 lines by date of service, and recode only the ones still inside the filing window. Write off the rest and record why, so the same encounters do not resurface next quarter.
The habit matters more than this one code. Checking status while you code, instead of when the denial arrives, is what stops a retired J-code from turning into a write-off. Book a demo to see how Pabau keeps code status, documentation, and claims in one place.
Continue your research
Billing a cardiac device or implant on the same claim? HCPCS code C1876 explains how the code is reported and what documentation the payer expects.
Coding the imaging side of a stress study? HCPCS code G0235 covers PET imaging that falls outside the specified indications, including its coverage limits.
Need the anesthesia code that pairs with a procedure? CPT code 01620 walks through unit calculation, modifiers, and the documentation that supports the claim.
Releasing records to support an appeal? HIPAA medical release form gives you a compliant authorization to use before you share anything with a payer.
Reporting supplies alongside a drug line? HCPCS code B4083 shows how supply codes define their own units and what that means for your claim.
Frequently asked questions
What is HCPCS code J0395?
HCPCS code J0395 is a deleted Level II HCPCS J-code that previously described injection, arbutamine HCl, 1 mg. It billed for arbutamine hydrochloride, sold as GenESA, a synthetic catecholamine given intravenously. The drug acted as a pharmacological stress agent during cardiac stress testing for patients unable to exercise adequately.
Is HCPCS code J0395 still active or has it been deleted?
J0395 has been deleted and is no longer valid on current claims. Submitting it to Medicare or a commercial payer will draw an automatic denial. Practices with outstanding historical encounters should recode to J3490 with supporting drug documentation, provided the timely filing window has not expired.
What is the replacement or crosswalk code for J0395?
There is no official CMS-designated replacement for J0395. The standard fallback is J3490, the unclassified drug code. It requires the drug name, dosage, NDC, route of administration, and a medical necessity narrative attached to the claim. Verify your MAC’s specific J3490 submission requirements before resubmitting.
Do I need to apply the JW or JZ modifier when billing injectable drug J-codes?
Yes, on Medicare claims for single-dose vial drugs. The JW modifier has been required for discarded drug from a single-dose vial since 2017. Mandatory JZ reporting, used when no amount is discarded, took effect July 1, 2023. One of the two must appear on the claim line. Commercial payer requirements vary, so check payer policy before applying these modifiers to non-Medicare claims.
Which ICD-10-CM diagnosis codes support medical necessity for cardiac stress testing?
Several codes support pharmacological cardiac stress testing. They include I25.10 (atherosclerotic heart disease without angina), R07.9 (chest pain, unspecified), I20.9 (angina pectoris, unspecified), and I25.2 (old myocardial infarction). A secondary code documenting inability to exercise strengthens the case for pharmacological rather than exercise stress testing.
What NDC code corresponds to arbutamine HCl for billing purposes?
The NDC for arbutamine HCl (GenESA) was assigned by Gensia Automedics, the original manufacturer, later Sicor. The drug may no longer be commercially available. Verify the current NDC through the FDA’s NDC directory or your pharmacy supplier before attaching it to a claim. Never bill an NDC you cannot verify against current drug availability records.
What is the status of HCPCS code J0395 in 2026?
As of the 2026 HCPCS code set, J0395 remains deleted and inactive. It does not appear in the active code list published by CMS in the annual HCPCS update. Confirm status against the CMS HCPCS annual update files, or your payer’s own code list, before submitting any claim.